HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can ataxin-2 be down-regulated by allele-specific de novo DNA methylation in SCA2 patients?

Abstract
Spinocerebellar ataxia type 2 (SCA2) is caused by a CAG trinucleotide repeat expansion within the coding region of the ataxin-2 gene. Affected individuals typically have between 34 and 57 CAG repeats. Signs of the disorder generally begin in adulthood and include progressive ataxia, dysarthria, tremor, hyporeflexia, and slow saccades. As with other trinucleotide repeat disorders, SCA2 exhibits an inverse correlation between the size of the CAG repeat and the age at onset of clinically detectable disease, with neonatal cases of SCA2 being reported in individuals harboring over 200 CAG repeats. However, a wide range of age at onset is typically observed, especially in individuals with < 40 CAG repeats. CAG repeat number alone explains approximately 25-80% of the variability. In this paper, we hypothesize that the level of mutant ataxin-2 protein in affected cells contributes to these differences. One of the mechanisms that might influence this protein levels is de novo DNA methylation, which would specifically target the allele with the expanded CAG repeat leading to transcriptional silencing. Consequently, the symptoms of SCA2 would occur later in the patient's life history. Our postulations, as well as those previously reported to account for the phenotype of SCA2, are discussed.
AuthorsP O Bauer, A Zumrova, V Matoska, K Mitsui, P Goetz
JournalMedical hypotheses (Med Hypotheses) Vol. 63 Issue 6 Pg. 1018-23 ( 2004) ISSN: 0306-9877 [Print] United States
PMID15504570 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ataxins
  • Biomarkers, Tumor
  • Genetic Markers
  • Nerve Tissue Proteins
  • Proteins
Topics
  • Alleles
  • Ataxins
  • Biomarkers, Tumor (metabolism)
  • DNA Methylation
  • Down-Regulation (genetics)
  • Genetic Markers (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Humans
  • Models, Biological
  • Nerve Tissue Proteins
  • Proteins (genetics, metabolism)
  • Spinocerebellar Ataxias (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: